WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Carminia Della Corte
PeerJ Editor & Reviewer
550 Points

Contributions by role

Reviewer 50
Editor 500

Contributions by subject area

Biotechnology
Oncology
Bioinformatics
Cell Biology
Respiratory Medicine
Drugs and Devices
Internal Medicine
Molecular Biology
Urology
Clinical Trials
Epidemiology
Surgery and Surgical Specialties
Women's Health
Gastroenterology and Hepatology

Carminia Maria Della Corte

PeerJ Editor & Reviewer

Summary

-09/01/2018-current: Postdoc researcher at MDACC, Houston, Thoracic Head and Neck department, PI: Lauren Byers

-05/07/2012 – 04/07/2017: Residency in Medical Oncology (50/50 cum laude) at Second University of Naples, research thesis in:“Role of Hedgehog pathway in the acquisition of resistance to EGFR inhibitors in EGFR mutant non small cell lung cancer models”

- 10/10/2011: Degree in Medicine (110/110 cum laude), at Second University of Naples, research thesis in “Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors”

-Multiple first-name and co-authored publications in Transnational research in Oncology field.

Biotechnology Cell Biology Oncology

Editorial Board Member

PeerJ - the Journal of Life & Environmental Sciences

Past or current institution affiliations

Anderson University

Work details

Postdoc

Anderson University
January 2018
THNMO
Carminia M. Della Corte, M.D., is a postdoctoral fellow in the department of Thoracic/Head and Neck Medical Oncology at MD Anderson Cancer Center. Dr. Della Corte’s research studies, under the direction of Dr. Byers, are focused on identifying mechanisms of resistance to therapies in lung cancer and developing tailored strategies to overcome resistance and optimize patient selection.

Websites

  • PubMed Search

PeerJ Contributions

  • Edited 5
  • Reviewed 1

Academic Editor on

April 28, 2020
Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells
Xin Gao, Xiaohong Wen, Haowei He, Linlin Zheng, Yibo Yang, Jinlian Yang, Haifang Liu, Xiguo Zhou, Changshun Yang, Yinyi Chen, Mei Chen, Shufang Zhang
https://doi.org/10.7717/peerj.9078 PubMed 32377458
February 3, 2020
Radiotherapy after mastectomy has significant survival benefits for inflammatory breast cancer: a SEER population-based retrospective study
Zhi-wen Li, Miao Zhang, Yong-jing Yang, Zi-jun Zhou, Yan-ling Liu, Hang Li, Bo Bao, Jian-dong Diao, Dun-wei Wang
https://doi.org/10.7717/peerj.8512 PubMed 32117621
December 3, 2019
Different distant metastasis patterns based on tumor size could be found in extensive-stage small cell lung cancer patients: a large, population-based SEER study
Jia Li, Feng Liu, Haining Yu, Chenglong Zhao, Zhenxiang Li, Haiyong Wang
https://doi.org/10.7717/peerj.8163 PubMed 31824772
December 2, 2019
Co-expression analysis and ceRNA network reveal eight novel potential lncRNA biomarkers in hepatocellular carcinoma
Ren-chao Zou, Zhi-tian Shi, Shu-feng Xiao, Yang Ke, Hao-ran Tang, Tian-gen Wu, Zhi-tang Guo, Fan Ni, Sanqi An, Lin Wang
https://doi.org/10.7717/peerj.8101 PubMed 31824761
September 24, 2019
Efficacy of Paclitaxel plus TS1 against previously treated EGFR mutated non-small cell lung cancer
Yen-Han Tseng, Jen-Fu Shih, Heng-Sheng Chao, Yuh-Min Chen
https://doi.org/10.7717/peerj.7767 PubMed 31579626

Signed reviews submitted for articles published in PeerJ Note that some articles may not have the review itself made public unless authors have made them open as well.

February 7, 2019
Co-expression of HIF-1α, MDR1 and LAPTM4B in peripheral blood of solid tumors
Zaira Rehman, Ammad Fahim, Attya Bhatti, Hajra Sadia, Peter John
https://doi.org/10.7717/peerj.6309 PubMed 30746305